Media

All Media Articles

Newest first · Page 418

Cramer Thinks the Bears Are Losing

On today’s Wall Street Confidential video on TheStreet.com, Cramer is following Bear Stearns (BSC-NYSE) pop and interpreting that this means subprime is just not a huge worry right now like it was.  Cramer noted…

Douglas A. McIntyre · 20 years ago

More Carnage Coming in Newspaper Stocks

Goldman Sachs has another ghastly report for newspapers.  You know a report is going to be bad when it starts out with The good news for publishers: 2006 is over.  The bad news for…

Douglas A. McIntyre · 20 years ago

Media Digest 3/29/2007 Reuters, WSJ, NYTimes, FT, Barron’s

According to Reuters, Citigroup (C) plans to double the number of branchs it has in China. Reuters writes that GM (GM) management will not take bonuses for 2006. Reuters writes that Toyota (TM) will…

Douglas A. McIntyre · 20 years ago

Cramer Backs Two More CEO’s

Cramer on MAD MONEY tonight added two more CEO’s that you can give the benefit of the doubt.  These will make its numbers longer-term.  Here are Cramer’s 2 more CEO’s:

Douglas A. McIntyre · 20 years ago

Cramer’s 2 Activist Hopefuls

Cramer on CNBC’s MAD MONEY referred back to activist shareholders coming in, and he referred back to Heinz.  With the Cadburry deal adding huge value Cramer wanted to know who else could benefit from…

Douglas A. McIntyre · 20 years ago

Cramer’s Telecom & More

On today’s STOP TRADING segment on CNBC, Jim Cramer came out talking about of all things a waterproof cellular phone in response to Erin Burnette’s question but he said the Apple (AAPL-NASDAQ) iPhone is…

Douglas A. McIntyre · 20 years ago

Media Digest 3/28/2007 Reuters, WSJ, NYTimes, FT, Barron’s

According to Reuters, media reports indicate that GM (GM) will not make a bid for the Chrysler unit of DaimlerChrysler (DCX) Retuers reports that Hewlett-Packard (HPQ) is suing PC company Acer in a move…

Douglas A. McIntyre · 20 years ago

MDP: More Restructuring for Meredith Corporation

By William Trent, CFA of Stock Market Beat When Meredith Corporation (MDP) reported earnings, we noted: This was slightly ahead of expectations, due in part to strong advertising trends. However, the guidance was ever…

Douglas A. McIntyre · 20 years ago

Cramer Notes Two CEO’s You Can Bet On

Cramer on CNBC’s MAD MONEY also had another two CEO’s that you can count as one who deserves the benefit of the doubt on: Cramer thinks that a retailer CEO that can be given…

Douglas A. McIntyre · 20 years ago

Cramer Reviews His Top Picks for 2007

On tonight’s MAD MONEY on CNBC, Jim Cramer discussed his TOP PICKS FOR 2007 as top stocks.  He noted his runner ups in these too.  Here is how they have done so far this…

Douglas A. McIntyre · 20 years ago

Reuters Gets Some Competition

Big news and financial information company Reuters (RTRSY) just hit a 52-week high, moving over $55. That is quite a contrast to the $10 price in 2003. Then cancellations of its quote/news terminals driven…

Douglas A. McIntyre · 20 years ago

Cramer’s Second Round of Window Dressing Picks

On today’s STOP TRADING segment on CNBC, Cramer again talked piggybacking on window dressing at the end of the quarter (this Friday). Tesoro (TSO) and Avnet (AVT) were noted.  Vulcan Materials (VMC) and Florida…

Douglas A. McIntyre · 20 years ago

Cramer’s Window Dressing Candidates

On today’s WALL STREET CONFIDENTIAL video on TheStreet.com, Cramer talked about quarterly window dressing where portfolio managers want to show stocks that have gone up.  The quarter ends this Friday. It can move the…

Douglas A. McIntyre · 20 years ago

Media Digest 3/27/2007 Reuters, WSJ, NYTimes, FT, Barron’s

According to Reuters, the non-profit open source group that controls most of the Linux code base will try to prevent (MSFT) and Novell (NOVL) from jointly marketing Windows and Linux. Reuters writes that Merck…

Douglas A. McIntyre · 20 years ago

Cramer Pick: Activist Investors & Underperforming Management

Cramer also has a pick of underperforming management and activist activity.  This pick is PDL BioPharma (PDLI-NASDAQ).  The company gets royalties from Avastin and Herceptin from Genentech, but the company has made many bad…

Douglas A. McIntyre · 20 years ago